Bristol Myers Squibb Promotes Health Equity with 100 Percent of Marketed Products Now Supported by Access Plans
At BMS, our vision to transform patients’ lives through science extends to all patients. That is why we have a long-standing commitment to promote health equity and help people in underserved communities access the care and medicines they need.
Bristol Myers Squibb's Commitment to Environment, Social and Governance: Our Progress & Aspirational Goals
At BMS, we understand that the future of our company, employees, communities, and the planet are inextricably linked. Our passion for making an impact extends beyond the discovery, development and delivery of innovative medicines that help patients prevail over serious diseases.
Bristol Myers Squibb Reaches Major Milestone in Environmental Sustainability
BMS today announced validation for its near-term and net-zero science-based targets from the Science Based Targets initiative (SBTi), as part of a mid-year update on its environmental initiatives, highlighting progress in reducing emissions across its operations and supply chain.
BMS Named 2024 Best Place to Work for Disability Inclusion in US, UK and Brazil by the Disability Equality Index®
BMS has earned a top score of 100 on the 2024 Disability Equality Index®, naming BMS a Best Place to Work for Disability Inclusion in the U.S., U.K. and Brazil. BMS has earned this score for the sixth consecutive year in the U.S. and for the first time in the U.K. and Brazil.
ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries
Globally, communities are struggling to support growing healthcare needs. This is especially true in regions with limited financial resources, collectively known as low- and middle-income countries (LMICs). Although LMIC populations have grown nearly four times faster.
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries
BMS announced ASPIRE (Accessibility, Sustainability, Patient-centric, Impact, Responsibility and Equity), a 10-year strategy to advance access to our innovative treatments and help patients in low- and middle-income countries.
Building a Better Future: Bristol Myers Squibb 2023 ESG Report
Since 1887, BMS has enabled positive change for patients around the world, and I am honored to continue this legacy as Board Chair and CEO. Our obligation to advance this legacy is profound.
Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals
Bristol Myers Squibb published its 2023 Environmental, Social, and Governance (ESG) Report detailing the company’s meaningful progress, evolved strategy, and aspirational goals toward its ESG efforts.
Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes
Bristol Myers Squibb (NYSE: BMY) unveiled a $1.8 million initiative to advance health equity by addressing social determinants of health (SDoH) in four countries with underserved patient needs, including Brazil, India, Thailand, and the United Kingdom.